AlTi Global’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
7,279
+5
+0.1% +$141 ﹤0.01% 494
2026
Q1
$208K Sell
7,274
-9
-0.1% -$307 ﹤0.01% 419
2025
Q4
$288K Sell
7,283
-35
-0.5% -$1.28K 0.01% 388
2025
Q3
$258K Buy
7,318
+54
+0.7% +$1.86K 0.01% 393
2025
Q2
$238K Buy
7,264
+1
+0% +$32 0.01% 385
2025
Q1
$234K Hold
7,263
0.01% 361
2024
Q4
$222K Hold
7,263
0.01% 390
2024
Q3
$204K Buy
+7,263
New +$179K ﹤0.01% 371
2024
Q2
Sell
-7,263
Closed -$221K 384
2024
Q1
$221K Hold
7,263
0.01% 356
2023
Q4
$259K Buy
+7,263
New +$270K 0.01% 307

Other funds holding ATRC

AlTi Global's ATRC Position: Q2 2026 in Review

AlTi Global increased its AtriCure (ATRC) stake by 0.07% in Q2 2026, buying an estimated $141 and bringing the position to 7,279 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

AlTi Global first reported a position in ATRC in Q4 2023 and has held it in 10 quarters since. The position peaked at $288K in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • AlTi Global held 7,279 shares of AtriCure worth $204K as of Q2 2026.
  • AlTi Global bought 5 AtriCure shares in Q2 2026, an estimated $141.
  • AtriCure made up ﹤0.01% of AlTi Global's portfolio in Q2 2026, its #494 holding.
  • AlTi Global first reported a position in AtriCure in Q4 2023 and has held it in 10 quarters since.
  • AlTi Global's AtriCure position peaked at $288K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.